首頁 > 市場調查報告書 > 製藥

疫苗感染疾病

市場調查報告書

商品編碼

1608827

腦膜炎疫苗市場：依類型、品牌、血清型、銷售管道、地區

Meningitis Vaccines Market, By Type, By Brand, By Serotype, By Sales Channel, By Geography

出版日期: 2024年11月08日 | 出版商:

Coherent Market Insights | 英文 359 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年腦膜炎疫苗市場規模為37.2億美元，2031年將達58.1億美元，2024年至2031年複合年成長率為6.6%。

分析範圍		分析詳情
基準年	2023年	市場規模（2024年）	37.2億美元
實際資料	2019-2023	預測期	2024-2031
預測期複合年成長率（2024-2031）	6.60%	預計金額（2031年）	58.1億美元

圖：2024 年按地區分類的腦膜炎疫苗市場佔有率（%）

腦膜炎是覆蓋大腦和脊髓的保護膜（稱為腦膜）的致命發炎。腦膜炎是由多種病原體引起的，包括細菌、病毒、寄生蟲和真菌。腦膜炎最常見的原因是病毒和細菌感染。如果不及時使用適當的抗生素治療，由腦膜炎奈瑟菌、肺炎鏈球菌和 B 型流感嗜血桿菌引起的細菌感染可能會迅速惡化並致命。雖然及時使用抗生素治療可以治癒大多數細菌性腦膜炎病例，但感染疾病仍會導致長期殘疾，例如 10-15% 的病例可能導致聽力喪失、神經發育遲緩、癲癇和截肢。建議接種疫苗以預防腦膜炎奈瑟菌引起的侵襲性腦膜炎雙球菌疾病的發生。腦膜炎雙球菌結合疫苗的開發可提供直接保護和群體免疫，有效控制疾病在社區內的傳播。

市場動態

腦膜炎疫苗的全球市場成長主要是由侵襲性腦膜炎雙球菌病菌感染負擔的增加和全球大規模免疫計畫的實施所推動的。例如，根據世界衛生組織（WHO）2021年發布的資料，腦膜炎每年導致約25萬至50萬例病例和超過3萬人死亡，使其成為公共衛生重點。導致疫情爆發的常見致病血清群的流行病學不斷發展、國家監管機構對常規免疫的建議以及組合疫苗的可用性預計將在預測期內增加市場供應量，從而提供強勁的成長機會。然而，製造和開發新疫苗的高成本、疫情期間疫苗缺貨以及低收入和中等收入國家缺乏意識等因素可能會阻礙市場成長。涵蓋新興血清型的廉價多效價疫苗的市場開拓以及開發中國家免疫規劃的擴大為參與者進入並進一步擴大市場提供了有利可圖的機會。

本研究的主要特點

該報告對全球腦膜炎疫苗市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、績效和策略等參數，包括全球腦膜炎疫苗市場的主要企業概況。

主要企業包括輝瑞、賽諾菲、葛蘭素史克、印度血清研究所有限公司、默克公司、沃森生物科技有限公司、伊西普達製藥有限公司、華蘭生物工程有限公司等。

從這份報告中獲得的見解將幫助負責人和公司經營團隊就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。

全球腦膜炎疫苗市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	3.72 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	6.60%	2031 Value Projection:	5.81 Bn

Meningitis is a potentially fatal inflammation of the protective membranes covering the brain and spinal cord known as meninges. It can be caused by various pathogens such as bacteria, viruses, parasites, and fungi. The most common causes of meningitis are viral and bacterial infections. Bacterial infections including those caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b can rapidly lead to serious illness and even death if not treated promptly with appropriate antibiotics. While timely treatment with antibiotics can cure most cases of bacterial meningitis, the infection may still lead to long-term disability in 10-15% of cases such as hearing loss, neurodevelopmental delay, and epilepsy or limb amputations. To prevent the occurrence of invasive meningococcal disease caused by N. meningitidis, vaccination is recommended. Meningococcal conjugate vaccines have been created to provide both direct protection and herd immunity, effectively controlling the spread of the disease within communities.

Market Dynamics

Global meningitis vaccines market growth is primarily driven by increasing burden of invasive meningococcal disease and implementation of large-scale immunization programs worldwide. For instance, as per the data published by the World Health Organization (WHO) in 2021, meningitis causes approximately 250,000-500,000 cases annually resulting in over 30,000 deaths, making it a public health priority. Evolving epidemiology of common pathogenic serogroups causing outbreaks, recommendations for routine immunization by national regulatory bodies and availability of vaccine combinations are expected to create robust growth opportunities in the market during the forecast period. However, factors such as high costs associated with the manufacturing and development of novel vaccines, vaccine stockouts during outbreaks, and lack of awareness in low and middle-income countries can hamper the market growth. Development of affordable multivalent vaccines covering emerging serotypes and expansion of immunization programs in developing nations present lucrative opportunities for player engagement and further market expansion.

Key Features of the Study

This report provides in-depth analysis of the global meningitis vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global meningitis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., Sanofi, GSK plc., Serum Institute of India Ltd., Merck & co., Inc., Walvax Biotechnology Co., Ltd., Icepta Pharmaceuticals Ltd., and Hualan Biological Engineering Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Market Segmentation

Type Insights
- Bivalent
- Quadrivalent
- Others
Brand Insights
- MenQuadfi
- Menveo
- Trumenba
- Bexsero
- Others
Age Group Insights
- Infants
- Adults
Serotype Insights
- Serotype A
- Serotype B
- Serotype C
- Serotype W-135
- Others
Sales Channel Insights
- Private
- Public
Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Sanofi
- GSK plc.
- Serum Institute of India Ltd.
- Merck & co., Inc.
- Walvax Biotechnology Co., Ltd.
- Icepta Pharmaceuticals Ltd.
- Hualan Biological Engineering Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Meningitis Vaccines Market, By Type
- Meningitis Vaccines Market, By Brand
- Meningitis Vaccines Market, By Age Group
- Meningitis Vaccines Market, By Serotype
- Meningitis Vaccines Market, By Sales Channel
- Meningitis Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology

4. Meningitis Vaccines Market, By Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Bivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Quadrivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Meningitis Vaccines Market, By Brand, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
MenQuadfi
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Menveo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Trumenba
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Bexsero
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Meningitis Vaccines Market, By Age Group, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Infants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Meningitis Vaccines Market, By Serotype, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Serotype A
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Serotype B
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Serotype C
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Serotype W-135
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Meningitis Vaccines Market, By Sales Channel, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Meningitis Vaccines Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country/Region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa

10. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Serum Institute of India Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Walvax Biotechnology Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Icepta Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hualan Biological Engineering Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies